Antimalarial therapy: a panacea for mild lupus? (Q34226976)

31 July 2017

1 reference

title

Antimalarial therapy: a panacea for mild lupus? (English)

1 reference

31 July 2017

0 references

D D'Cruz

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

148-151

1 reference

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

The prevalence and associations of fatigue in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine and postoperative thromboembolism after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

4-Aminoquinoline antimalarials enhance UV-B induced c-jun transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Retinal toxicity in long term hydroxychloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120301669779293

10.1191/096120301669779293

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference